Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison between rifaximin vs lactulose for treatment of hepatic encephalopathy
TCTR20180509001Phase 3Recruiting
- Sponsor
- Bio-innova
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rifaximin, lactulose in hepatic encephalopathy (HE), sponsored by Bio-innova. Started Dec 2016; status: recruiting.
02
Drugs
rifaximinlactulose
03
Conditions
hepatic encephalopathy (HE)
Beyond the preview
Go deeper on TCTR20180509001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180509001.